Seqstant offers real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
Seqstant has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in November 2023.
Seqstant's investors include Brandenburg Kapital, Saarbruecker 21, HPI Seed Fund, Venture League.
Seqstant is headquartered in Teltow, Germany.
Seqstant offers real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
Seqstant is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seqstant — Funding & Investors." VCBacked, November 5, 2023, https://www.vcbacked.co/company/seqstant. Accessed August 13, 2026.
VCBacked. (2023). Seqstant — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/seqstant
{{cite web |title=Seqstant — Funding & Investors |url=https://www.vcbacked.co/company/seqstant |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated